alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# L_2022279EN.01002801.xml

| 27.10.2022 | EN | Official Journal of the European Union | L 279/28 |
| --- | --- | --- | --- |

27.10.2022

EN

Official Journal of the European Union

L 279/28

---

DECISION OF THE EEA JOINT COMMITTEE No 123/2019

of 8 May 2019

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2022/2021]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Regulation (EU) 2018/1847 of 26 November 2018 amending Annex V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Regulation (EU) 2018/1847 of 26 November 2018 amending Annex V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (1) is to be incorporated into the EEA Agreement.

| (2) | Annex II to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(2)

Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 1a (Regulation (EC) No 1223/2009 of the European Parliament and of the Council) of Chapter XVI of Annex II to the EEA Agreement:

| ‘— | 32018 R 1847: Commission Regulation (EU) 2018/1847 of 26 November 2018 (OJ L 300, 27.11.2018, p. 1).’ |
| --- | --- |

‘—

32018 R 1847: Commission Regulation (EU) 2018/1847 of 26 November 2018 (OJ L 300, 27.11.2018, p. 1).’

Article 2

The text of Regulation (EU) 2018/1847 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 1 June 2019, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 8 May 2019.

For the EEA Joint Committee

The President

Claude MAERTEN

---

(1)  
  OJ L 300, 27.11.2018, p. 1.

1

(*)  No constitutional requirements indicated.

*

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Synthetic and Biological Chemistry A Study Section.                    

*Date:*                         January 31-February 1, 2019.                    

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hotel Spero, 405 Taylor Street, San Francisco, CA 94102.                    

*Contact Person:*                         Anita Szajek, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4187, Bethesda, MD 20892, 301-827-6276,                         *anita.szajek@nih.gov.*

This meeting notice is being published less than 15 days in advance of the meeting due to the partial Government shutdown of December 2018.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: January 18, 2019.

Natasha M. Copeland,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2019-00171 Filed 1-25-19; 8:45 am]

 BILLING CODE 4140-01-P
BISNIS TRADES & TENDERS, AUGUST 4, 1997

----

BISNIS TRADES & TENDERS, AUGUST 4, 1997
THE BUSINESS INFORMATION SERVICE FOR THE NEWLY INDEPENDENT STATES (BISNIS)HAS CREATED THE BISNIS TRADES AND TENDERS ELECTRONIC NEWSLETTER TO HELP U.S.COMPANIES FIND BUSINESS OPPORTUNITIES IN THE EXPANDING MARKETS OF THE NEWLYINDEPENDENT STATES (NIS) OF THE FORMER SOVIET UNION.
THESE OPPORTUNITIES ARE PROVIDED SOLELY AS AN INFORMATIONAL SERVICE AND DONOT REPRESENT AN ENDORSEMENT BY THE U.S. DEPARTMENT OF COMMERCE.VERIFICATION OF LEADS IS THE RESPONSIBILITY OF THE READER. BISNIS MAY CONSIDEROTHER PRIVATE SECTOR-GENERATED TRADE LEADS AND TENDERS, IN ELECTRONIC FORMONLY, AND PUBLISH ON A SPACE-AVAILABLE BASIS. PLEASE SEND YOUR LEADS TO[email protected]
[Federal Register Volume 84, Number 20 (Wednesday, January 30, 2019)]
[Notices]
[Page 481]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00278]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR 18-039: Intellectual and Developmental Disabilities 
Outcomes.
    Date: February 8, 2019.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The William F. Bolger Center, 9600 Newbridge Drive, 
Potomac, MD 20854.
    Contact Person: Katherine Colona Morasch, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3170, Bethesda, MD 20892, 
<a href="/cdn-cgi/l/email-protection#64090b160517070c0f07240717164a0a0d0c4a030b12"><span class="__cf_email__" data-cfemail="80edeff2e1f3e3e8ebe3c0e3f3f2aeeee9e8aee7eff6">[email protected]</span></a>.

    This meeting notice is being published less than 15 days in 
advance of the meeting due to the partial Government shutdown of 
December 2018.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: January 23, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-00278 Filed 1-29-19; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
SUPREME COURT OF THE STATE OF NEW YORK

Appellate Division, Fourth Judicial Department

683 

CAF 13-00823 

PRESENT: CENTRA, J.P., LINDLEY, SCONIERS, VALENTINO, AND DEJOSEPH, JJ. 

 

IN THE MATTER OF TRISTYN R. 

--------------------------------------- 

CATTARAUGUS COUNTY DEPARTMENT OF SOCIAL MEMORANDUM AND ORDER

SERVICES, PETITIONER-RESPONDENT; 

 

JACQUELINE Z., RESPONDENT-APPELLANT,

AND JOSHUA R., RESPONDENT. 

ERICKSON WEBB SCOLTON & HAJDU, LAKEWOOD (LYLE T. HAJDU OF COUNSEL),

FOR RESPONDENT-APPELLANT. 

STEPHEN J. RILEY, OLEAN, FOR PETITIONER-RESPONDENT. 

MICHAEL D. BURKE, ATTORNEY FOR THE CHILD, OLEAN.

 

Appeal from an order of the Family Court, Cattaraugus County

(Michael L. Nenno, J.), entered April 8, 2013 in a proceeding pursuant

to Family Court Act article 10. The order, among other things,

adjudged that respondents neglected the subject child. 

It is hereby ORDERED that the order so appealed from is

unanimously affirmed without costs.

Memorandum: Respondent mother appeals from an order adjudicating

her son to be a neglected child. Contrary to the mother’s contention,

Family Court’s determination that the subject child was derivatively

neglected is supported by a preponderance of the evidence (see Family

Ct Act § 1046 [b] [i]; Matter of Jonathan S., 53 AD3d 1089, 1090, lv

denied 11 NY3d 709). We reject the mother’s contention that the

evidence is insufficient to support the finding of derivative neglect

because the only allegation of misconduct occurred more than two years

prior to the subject child’s birth and was limited to the abuse of the

mother’s eldest child by respondent father, the subject child’s

father. The record reflects that the mother lacked an 

“ ‘understanding of the duties and obligations of parenthood and

created an atmosphere detrimental to the physical, mental and

emotional well-being of [the subject child]’ ” (Matter of Kaylene S.

[Brauna S.], 101 AD3d 1648, 1649, lv denied 21 NY3d 852). “[I]nasmuch

as the paramount purpose of Family [Court] Act article 10 is the

protection of the ‘physical, mental, and emotional well-being’ of

children . . . , and mindful of the particular vulnerability attendant

to newborn infants such as the child herein . . . , we conclude that

Family Court’s finding of derivative neglect is justified on this 
-2- 683 

CAF 13-00823 

record” (Matter of Evelyn B., 30 AD3d 913, 917, lv denied 7 NY3d 713).

Entered: June 20, 2014 Frances E. Cafarell

Clerk of the Court
B.C.D. 15-06

EMPLOYER STATUS DETERMINATION

CCET, LLC

March 27, 2015

This is the determination ofthe Railroad Retirement Board concerning the status of

CCET, LLC (CCET), as an employer under the Railroad Retirement Act (45 U.S.C. 

§ 231 et seq.) and the Railroad Unemployment Insurance Act (45 U.S.C. §351 et

sea).

Information regarding CCET was supplied by James H. M. Savage, attorney for

CCET. The Chief Executive Officer and owner is Paul Didelius and CCET does

business under the trade name Cincinnati East Terminal Railway. Operations

began on April 27, 2014. CCET operates a 23.83 mile portion of the CT Line of

Norfolk Southern Railroad, a covered employer (Norfolk Southern). The CT Line

operated by CCET extends between milepost CT 9.0 at Clare, Ohio and milepost CT

32.83, west of Williamsburg, Ohio. CCET interchanges freight cars with Norfolk

Southern at Clare Yard and holds itself out as capable of providing common carrier

service to local freight customers on the line. Estimated initial annual freight

volume will be 700 cars. CCET has two employees who began to be compensated

on May 2, 2014.

In Surface Transportation Board Finance Docket No. 35810, CCET filed a notice of

exemption to lease from Norfolk Southern Railway Company, and to operate,

pursuant to a lease agreement dated March 14, 2014, an approximately 24-mile

portion ofNorfolk Southern’s CT Line, extending between milepost CT 9.0 at Clare, 

Ohio, east ofClare Yard, and milepost CT 32.83, west of Williamsburg, Ohio, and 

passing through Hamilton County and Clermont Country, Ohio. According to

CCET, the lease does not contain any provisions that prohibits, restricts, or would

otherwise limit future interchange of traffic with any third-party carrier. CCET

states that it will hold itself out to provide all common carrier rail freight service 

over the line, with Norfolk Southern retaining limited overhead trackage rights. 

CCET certified that its projected annual revenues as a result ofthis transaction will

not exceed those that would qualify it as a Class III rail carrier.

Section 1(a)(1) of the Railroad Retirement Act (45 U.S.C. § 231(a)(1)), insofar as

relevant here, defines a covered employer as:

(i) any carrier by railroad subject to the jurisdiction of the

Surface Transportation Board under Part A of subtitle IV of title 49,

United States Code;

BA # 5340
2

Sections 1(a) and 1(b) ofthe Railroad Unemployment Insurance Act (45 U.S.C. §§

351(a) and (b)) contain substantially similar definitions, as does section 3231 ofthe

Railroad Retirement Tax Act (26 U.S.C. § 3231).

The evidence of record establishes that CCET is a carrier operating in interstate

commerce subject to STB jurisdiction. Accordingly, it is determined that CCET is

an employer within the meaning ofsection l(a)(l)(i) ofthe Railroad Retirement Act

(45 U.S.C. § 231 (a)( 1 )(i)) and the corresponding provision of the Railroad

Unemployment Insurance Act as of April 27, 2014, the date it began operations.

FOR THE BOARD

Martha P. Rico 

Secretary to the Board
[Federal Register Volume 84, Number 21 (Thursday, January 31, 2019)]
[Notices]
[Page 780]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00350]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; RC2: Precision 
Dietetics.
    Date: February 12, 2019.
    Time: 3:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Maria E. Davila-Bloom, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7017, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-7637, <a href="/cdn-cgi/l/email-protection#fe9a9f8897929fd39c9291919393be9b868a8c9fd090979a9a95d0909796d0999188"><span class="__cf_email__" data-cfemail="badedbccd3d6db97d8d6d5d5d7d7fadfc2cec8db94d4d3deded194d4d3d294ddd5cc">[email protected]</span></a>.

    This meeting notice is being published less than 15 days in 
advance of the meeting due to the partial Government shutdown of 
December 2018.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: January 25, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-00350 Filed 1-30-19; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.1

    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Quarterly Report of BAS Consulting, Inc. (the "Company")
on Form 10-QSB for the period ended March 31, 2004 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, B. Alva Schoomer,
Chief Executive Officer and Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that to my knowledge:

1.       The Report fully complies with requirements of section 13(a) or 15(d)
         of the Securities Exchange Act of 1934; and

2.       The information contained in the Report fairly presents, in all
         material respects, the financial condition and result of operations of
         the Company.


/s/ B. Alva Schoomer
B. Alva Schoomer
Chief Executive Officer and Chief Financial Officer
May 17, 2004
§ 1110.502 Firewalled. ( a ) A third party conformity assessment body must apply to NTIS for firewalled status if it is owned, managed, or controlled by a Person or Certified Person that is the subject of attestation or audit by the Accredited Conformity Assessment Body, applying the characteristics set forth under § 1110.501(a)(1).
( b ) The application for firewalled status of a third party conformity assessment body under paragraph (a) of this section will be accepted by NTIS where NTIS finds that: ( 1 ) Acceptance of the third party conformity assessment body for firewalled status would provide equal or greater assurance that the Person or Certified Person has information security systems, facilities, and procedures in place to protect the security of the Limited Access DMF than would the Person's or Certified Person's use of an independent third party third party conformity assessment body; and
( 2 ) The third party conformity assessment body has established procedures to ensure that: ( i ) Its attestations and audits are protected from undue influence by the Person or Certified Person that is the subject of attestation or audit by the Accredited Conformity Assessment Body, or by any other interested party;
( ii ) NTIS is notified promptly of any attempt by the Person or Certified Person that is the subject of attestation or audit by the third party conformity assessment body, or by any other interested party, to hide or exert undue influence over an attestation, assessment or audit; and
( iii ) Allegations of undue influence may be reported confidentially to NTIS. To the extent permitted by Federal law, NTIS will undertake to protect the confidentiality of witnesses reporting allegations of undue influence.
( c ) NTIS will review each application and may contact the third party conformity assessment body with questions or to request submission of missing information, and will communicate its decision on each application in writing to the applicant, which may be by electronic mail.
UNITED STATES


SECURITIES AND EXCHANGE COMMISSION





WASHINGTON, D.C. 20549





FORM 8-K





CURRENT REPORT


Pursuant To Section 13 OR 15(d) of The Securities Exchange Act of 1934








Date of Report (Date of earliest event reported):   September 29, 2015 (September 29, 2015)





_________________________________ CLARCOR Inc. __________________________________


(Exact name of registrant as specified in its charter)











Delaware1-1102436-0922490(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification Number)








840 Crescent Centre Drive, Suite 600, Franklin, TN      37067


(Address of principal executive offices)               (Zip Code)











Registrant's telephone number, including area code _____ 615-771-3100________________________________











________________________________________________________________________________________________


(Former name or former address, if changed since last report).











Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):





[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)





[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)





[  ] Pre-commencement communications pursuant to Rule 14d-2(b)under the Exchange Act (17 CFR 240.14d-2(b))





[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))








---







Item 5.02.   Departure of Directors or Certain Officers; Election of Directors; Appointment


of Certain Officers; Compensatory Arrangements of Certain Officers.





On September 29, 2015, the Board of Directors of CLARCOR Inc., a Delaware corporation (NYSE: CLC) (the “Company”) confirmed the appointment of Jacob Thomas as the President of the Company’s Engine/Mobile Group, replacing Sam Ferrise, a named executive officer of the Company.  Mr. Ferrise has been appointed as the Company’s Senior Business Development Officer.  On September 29, 2015, the Company issued a press release regarding the foregoing appointments, a copy of which is attached hereto.





Item 9.01 Financial Statements & Exhibits





Exhibit 99.1 - Press Release dated September 29, 2015











SIGNATURES





Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.





CLARCOR INC.











By __/s/Richard M. Wolfson ______________________ ___


Richard M. Wolfson


Vice President - General Counsel and Corporate Secretary





Date: September 29, 2015
<PAGE>

                                                                    EXHIBIT 32.2

              CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Armor Electric Inc. (the
"Company") on Form 10-QSB for the period ending December 31, 2007 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), Cheryl
Spousta-Schertzer, as Chief Financial Officer of the Company, certifies,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, to the best of her knowledge, that:

         (1) The Report fully complies with the requirements of section 13(a) of
the Securities Exchange Act of 1934; and

         (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.


February 20, 2008

                                                   /s/ Cheryl Spousta-Schertzer
                                                   ----------------------------
                                                   Cheryl Spousta-Schertzer,
                                                   Chief Financial Officer